News
The 10-Year Health Plan marks a significant step forward in building an NHS that is faster, fairer and fit for the future. At NICE, we’re ready to deliver - using our expanded remit to accelerate ...
The new approach will ensure that high-impact devices, diagnostics and digital tools recommended by NICE, that meet the most urgent needs, are nationally reimbursed and made available across the NHS - ...
In this guest blog, Dale Greenwood, mental health lead for East London NHS Foundation Trust, shares how his trust implemented ...
Evidence-based recommendations on nivolumab (Opdivo) plus ipilimumab (Yervoy) for untreated unresectable or metastatic colorectal cancer with high microsatellite instability in adults. Last reviewed: ...
Evidence-based recommendations on dostarlimab (Jemperli) with platinum-based chemotherapy for primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair ...
Green light for groundbreaking personalised cancer therapy that reprogrammes immune system We've recommended an innovative one-off cell therapy that could give hundreds of lymphoma patients precious ...
Groundbreaking one-off gene therapy approved for severe sickle cell disease People in England with severe sickle cell disease will be among the first to receive treatment using revolutionary CRISPR ...
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
This guideline covers the prevention and management of overweight, obesity and central adiposity in children, young people and adults. It brings together and updates all NICE's previous guidelines on ...
Evidence-based recommendations on tirzepatide (Mounjaro) for managing overweight and obesity in adults. Last reviewed: 23 December 2024 Next review: This guidance will be reviewed if there is new ...
NICE-recommended digital therapies for depression and anxiety could free up thousands of NHS therapist hours NHS Talking Therapies for anxiety and depression services saw record referrals in 2023/24.
Our position on the use of AI in evidence generation and reporting There are several potential benefits to using AI methods in health technology assessment (HTA). These must be balanced against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results